Cargando…
Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care
Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy mana...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375988/ https://www.ncbi.nlm.nih.gov/pubmed/25811494 http://dx.doi.org/10.5888/pcd12.140504 |
_version_ | 1782363661794279424 |
---|---|
author | Snyder, Margie E. Earl, Tara R. Gilchrist, Siobhan Greenberg, Michael Heisler, Holly Revels, Michelle Matson-Koffman, Dyann |
author_facet | Snyder, Margie E. Earl, Tara R. Gilchrist, Siobhan Greenberg, Michael Heisler, Holly Revels, Michelle Matson-Koffman, Dyann |
author_sort | Snyder, Margie E. |
collection | PubMed |
description | Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical–community linkages through team-based care, particularly for chronic disease prevention and management. |
format | Online Article Text |
id | pubmed-4375988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-43759882015-04-17 Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care Snyder, Margie E. Earl, Tara R. Gilchrist, Siobhan Greenberg, Michael Heisler, Holly Revels, Michelle Matson-Koffman, Dyann Prev Chronic Dis Special Topic Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical–community linkages through team-based care, particularly for chronic disease prevention and management. Centers for Disease Control and Prevention 2015-03-26 /pmc/articles/PMC4375988/ /pubmed/25811494 http://dx.doi.org/10.5888/pcd12.140504 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Special Topic Snyder, Margie E. Earl, Tara R. Gilchrist, Siobhan Greenberg, Michael Heisler, Holly Revels, Michelle Matson-Koffman, Dyann Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care |
title | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care |
title_full | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care |
title_fullStr | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care |
title_full_unstemmed | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care |
title_short | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care |
title_sort | collaborative drug therapy management: case studies of three community-based models of care |
topic | Special Topic |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375988/ https://www.ncbi.nlm.nih.gov/pubmed/25811494 http://dx.doi.org/10.5888/pcd12.140504 |
work_keys_str_mv | AT snydermargiee collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare AT earltarar collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare AT gilchristsiobhan collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare AT greenbergmichael collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare AT heislerholly collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare AT revelsmichelle collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare AT matsonkoffmandyann collaborativedrugtherapymanagementcasestudiesofthreecommunitybasedmodelsofcare |